ObsEva SA
OBSN | SW
Overview
Corporate Details
- ISIN(s):
- CH1260041939
- LEI:
- 549300PNZ0UEJVKN1618
- Country:
- Switzerland
- Address:
- CHEMIN DES AULX 12, 1228 PLAN-LES-OUATES
- Website:
- https://www.obseva.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ObsEva SA is a clinical-stage biopharmaceutical company that was focused on the development and commercialization of novel therapeutics for women's reproductive health and pregnancy. The company's main focus was on addressing serious conditions from conception to birth, including preterm labor. Its pipeline included Yselty (linzagolix), an oral GnRH antagonist which received European marketing authorization for the treatment of uterine fibroids. In February 2024, the company announced it was winding down its operations.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for ObsEva SA.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all ObsEva SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ObsEva SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-17 | N/A | Non-Executive member | Buy | None | 2,058.00 CHF |
| 2022-03-16 | N/A | Non-Executive member | Buy | None | 27,010.00 CHF |
| 2022-03-15 | N/A | Non-Executive member | Buy | None | 23,642.00 CHF |
| 2022-02-08 | N/A | Non-Executive member | Buy | None | 64,161.00 CHF |
| 2022-02-01 | N/A | Non-Executive member | Buy | None | 70,716.00 CHF |
| 2022-01-24 | N/A | Non-Executive member | Buy | None | 69,748.00 CHF |
| 2022-01-11 | N/A | Non-Executive member | Buy | None | 183,535.00 CHF |
| 2022-01-10 | N/A | Non-Executive member | Buy | None | 177,643.00 CHF |
